profit from every $100 of sales.
$0$100
Intelligent Bio Solutions
$2.10-6.67% today
-74.0% in 1 year
1-year low $1.441-year high $17.92
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Intelligent Bio Solutions sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $3.05 million in 2025, with -$10.6 million of profit last year.
SalesProfit
Intelligent Bio Solutions vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Intelligent Bio Solutions | No profit yet | ||
 Illumina | 37.9× · Expensive | ||
 Labcorp Holdings | 34.5× · Expensive | ||
 Quest Diagnostics | 28.8× · Fair price | ||
 Guardant Health | No profit yet |
AI analysis
An AI analyst reads Intelligent Bio Solutions's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 1 | 3 | 3 | |
| 0 | 0 | 1 | 1 | |
| -8 | -8 | -10 | -10 | |
| -8 | -9 | -9 | -9 | |
| -8 | -11 | -10 | -11 | |
| -1,368.00 | -1,270.00 | -63.80 | -20.00 | |
| – | 26.0% | 45.8% | 40.8% | |
| – | -671.2% | -330.5% | -341.5% | |
| – | -845.9% | -326.4% | -346.2% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 12 | 10 | 14 | 8 |
| Cash | 8 | 2 | 6 | 1 |
| Total debt | 0 | 1 | 1 | 0 |
| Total liabilities | 6 | 7 | 6 | 5 |
| 7 | 4 | 8 | 3 | |
| 0 | 0 | 0 | 1 | |
| -99.3% | -160.6% | -86.1% | -254.1% | |
| -125.4% | -279.9% | -121.9% | -352.7% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -3 | -7 | -10 | -10 | |
| 0 | 1 | 0 | 0 | |
| -4 | -8 | -10 | -10 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 0 | 0 | 0 | 0 |
Valuation
- –
- 0.6×
- –
- 0.2×
- 2.3×
- –
- –
- -142.3%
- -151.7%
- 0.0%
Profitability
- 40.8%
- -341.5%
- -346.2%
- -280.7%
- -87.2%
- -157.6%
- -197.9%
- -64.0%
- -90.0%
- 78.8%
Growth
- +55.8%
- –
- −1.2%
- –
- +78.4%
Financial health
- -0.1×
- 0.31
- 19.6%
- -132.3×
- 2.37
- 2.26
- 0.20
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 1%of 958
Top 11%of 889
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 13, 2026 | -1.80 | 1.40 | −228.6% |
| Feb 12, 2026 | -2.82 | 0.40 | −805.0% |
| Nov 12, 2025 | -3.50 | -1.50 | −133.3% |
| Aug 15, 2025 | -0.37 | -1.20 | +69.2% |
| May 13, 2025 | -0.44 | -2.80 | +84.3% |
| Feb 13, 2025 | -0.50 | -3.20 | +84.4% |
| Nov 7, 2024 | -0.70 | -0.53 | −32.1% |
| Sep 19, 2024 | -1.34 | -0.51 | −162.7% |
News
Physical AI Empowers Smart Mobility: LUXEED Builds a New Full-Scenario Intelligent EcosystemYahoo Finance · Nov 6, 2026Global Intelligent Edge Computing Module Market Report 2026 | NVIDIA, Dell, Siemens, Cisco and Intel Capitalize on Edge AI as Market Hits $12.35 Billion by 2030Yahoo Finance · Nov 2, 2026Intelligent Platform Management Interface (IPMI) - Global Strategic Business Report: Capitalize on a $9.9B Market by 2032 as Cisco, Dell, HPE, Intel and Microsoft Accelerate Data Center AutomationYahoo Finance · Oct 26, 2026Intelligent Scopes Unveils the ISC 100: The Solution Enabling Urology AI to Work Beside Any Cystoscopy Tower — No Replacement, No Rewiring, No CloudYahoo Finance · Oct 19, 2026Stock Market Today, Oct. 12: CCC Intelligent Solutions Surges 8% on Advanced Buyout TalksYahoo Finance · Oct 12, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
55No pass
Benjamin Graham
71Pass
Philip Fisher
44No pass
Peter Lynch
68Pass
Joel Greenblatt
0No pass
Charlie Munger
33No pass
Terry Smith
39No pass
Questions about Intelligent Bio Solutions
Is Intelligent Bio Solutions a good stock to buy?
A business with weak numbers that is not profitable yet. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Intelligent Bio Solutions AI analysis
What does Intelligent Bio Solutions do?
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It is in Medical - Diagnostics & Research.
Does Intelligent Bio Solutions pay a dividend?
No. Intelligent Bio Solutions does not pay a dividend at the moment.
Is Intelligent Bio Solutions stock halal?
Yes. Intelligent Bio Solutions passes our halal screen: its business is permitted and its debt is 4% of its market value, under the 30% limit. How we check
How has Intelligent Bio Solutions stock done over the past year?
Down 74.0% over the past twelve months, to $2.10. It traded between $1.44 and $17.92 and is 88.3% below its high.
Who are Intelligent Bio Solutions's competitors?
The largest listed companies in the same industry are Illumina, Labcorp Holdings, Quest Diagnostics and Guardant Health. The peers table on this page compares their profit, growth and price with Intelligent Bio Solutions's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.